Contact Information:

Media Contact

Nienke Swankhuisen
n.swankhuisen@elsevier.com
31-204-852-445

Twitter: elseviernews

http://www.elsevier.com




Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.

PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Cancer preventative surgery could become a thing of the past, new research suggests

Two studies open the door to a new approach to breast and ovarian cancer prevention


2015-09-10
(Press-News.org) Amsterdam, September 10, 2015 - Surgery to remove the breasts of women at increased risk of developing breast cancer may not be necessary in the future, according to research published in EBioMedicine. Two new studies looking at the effect the menstrual cycle has on the development of breast and ovarian cancer reveal alternative prevention strategies that may render surgery unnecessary.

Breast cancer is the most common cancer in women worldwide and ovarian cancer is the deadliest gynaecological cancer. Women who have inherited mutations in genes called BRCA1 and BRCA2 have a very high risk for breast and ovarian cancer. Women at high risk can opt for a double mastectomy to reduce the risk of breast cancer, or removal of their fallopian tubes and ovaries to reduce the risk of ovarian cancer.

However, the mutations also affect organs that control the menstrual cycle, which has a central role in the development of breast and ovarian cancer. Previous research has shown that specific hormones involved in controlling the menstrual cycle - in particular progesterone - have an effect on the development of cancer. In the breast, progesterone increases the amount of a protein called RANKL, which is one of the triggers for breast cancer.

This means that genetic predisposition to breast and ovarian cancer is a result of the effect the genetic mutations have on hormones that control the menstrual cycle, as well as the effect the mutations have on the cells that develop into tumors.

A new study by researchers at University College London, supported by The Eve Appeal, reveals that women who have a mutation in the BRCA1 or BRCA2 gene have less of a molecule called OPG in their blood. OPG blocks the effects of RANKL, and likely stopping it from triggering breast cancer. RANKL itself is not found at increased levels in the blood in women with a mutation in BRCA1 or BRCA2. However, OPG is unusually low in their blood.

The researchers say that taking a drug that copies the effect of OPG or reduces the effects of progesterone could potentially reduce a woman's risk of breast cancer, but more research is needed to determine whether this is a viable prevention strategy.

"Preventative surgery is quite a drastic measure and we're unsatisfied with the situation - we are aiming to prevent breast cancer, and findings from our research are a significant step forward in demonstrating the importance of why further research is critical in this arena," said lead author Professor Martin Widschwendter. "Women who develop breast cancer as a consequence of their mutation develop cancers associated with poor prognoses that are difficult to treat. Prevention without surgery is the ultimate goal and this study is the first proof of principle - we have identified a new target we can now use to decrease breast cancer risk."

Researchers report on a new mouse model in the second study. Developed by Professor. Louis Dubeau and colleagues at Keck School of Medicine, University of Southern California, USA, this new model helps researchers understand what's behind the effect of the menstrual cycle on the risk of breast and ovarian cancer.

The model uses genetically engineered mice that carry mutations in the equivalent of the human BRCA1 gene, not only in tissues corresponding to those at increased risk of cancer in human BRCA1 mutation carriers, but also in the organs that control the menstrual cycle: the ovaries and the pituitary gland. The model also enables researchers to confine BRCA1 mutations either to tissues at high risk of cancer or to tissues that control the menstrual cycle separately. This gives researchers a tool to understand the effects of the mutations on the menstrual cycle independently from their direct effects on the tissues in which the cancers start.

When developing the mouse model, the researchers observed that some ovarian cancers originate in tissues outside the ovaries and fallopian tubes, suggesting that removal of just the fallopian tubes may not always be an effective prevention strategy in humans.

"We know that the menstrual cycle has an effect on the development of these cancers, but we don't understand the mechanisms behind it," said Prof. Dubeau. "We wanted to develop a mouse model researchers could use to study ways of preventing breast and ovarian cancer in women with BRCA1 and BRCA2 mutations. We hope this will result in new approaches that will eliminate the need for surgery in the future."

More research is needed into the new prevention strategies. Prof. Widschwendter and the team want to test the effectiveness of OPG in preventing breast cancer, but until they are completely sure it works they cannot conduct a clinical trial to see if OPG prevents cancer development. Instead, in addition to taking advantage of the new mouse model developed in Prof. Dubeau's laboratory, they plan to trial treatment on women at high risk of breast cancer who are waiting for preventative surgery. Instead of waiting for cancer to develop, the trial will monitor biological changes in the tissues at risk of cancer to evaluate the effect of treatment on cancer prevention. The researchers need the support of the BRCA1 and BRCA2 community to take this next step, and will be inviting women to take part in their study.

Athena Lamnisos, Chief Executive of The Eve Appeal said: "This research demonstrates why our focus is on supporting leading edge medical research that seeks to understand how women-specific cancers start. This is a step towards decoding these cancers and understanding how we can develop effective methods of risk prediction and prevention.

"As the UK's only gynaecological cancer research charity, we are championing for more research into prevention, so that we can save significantly more lives and see a future where fewer women develop and more women survive women's cancers," she added.

INFORMATION:

Article details "Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers" by Martin Widschwendter, Matthew Burnell, Lindsay Fraser, Adam N. Rosenthal, Sue Philpott, Daniel Reisel, Louis Dubeau, Mark Cline, Yang Pan, Ping-Cheng Yi, D. Gareth Evans, Ian J. Jacobs, Usha Menon, Charles E. Wood, William C. Dougall (doi: 10.1016/j.ebiom.2015.08.037).

"A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State" by Ying Liu, Hai-Yun Yen, Theresa Austria, Jonas Pettersson, Janos Peti-Peterdi, Robert Maxson, Martin Widschwendter and Louis Dubeau (doi: 10.1016/j.ebiom.2015.08.034).

These articles appear online in EBioMedicine, in press, published by Elsevier. They are available as open access articles on ScienceDirect.

Notes to editors The Eve Appeal are supporting a range of research programmes into risk prediction and prevention in women who are at risk of developing breast and ovarian cancer; the full programme, BRCA PROTECT, is due to be launched in 2016.

About EBioMedicine The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access, rapid publication Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences. As the communities that border this interface are large and diverse, the scope of EBioMedicine covers the entire breadth of translational and clinical research within all disciplines of life and health sciences, ranging from basic science to clinical and public/global health science. The journal is committed to facilitating and incentivizing a robust and successful pipeline for improved human health globally (http://www.ebiomedicine.com).

About The Eve Appeal The Eve Appeal is the only UK national charity raising awareness and funding research in the five gynaecological cancers - ovarian, womb, cervical, vaginal and vulval. It was set up to save women's lives by funding groundbreaking research focused on developing effective methods of risk prediction, earlier detection and developing screening for these women-only cancers. The charity has grown and developed in parallel with its core research team, the Department of Women's Cancer at University College London (UCL), taking place in 31 institutions across 15 countries. It has played a crucial role in providing seed funding, core infrastructure funding and project funding in addition to campaigning to raise awareness of women-specific cancers. The world-leading research that we fund is ambitious and challenging but our vision is simple: A future where fewer women develop and more women survive gynaecological cancers. http://www.eveappeal.org.uk

About UCL The Research Department of Women's Cancer, at University College London (UCL), has an exceptionally dedicated group of academics and clinicians to conduct multidisciplinary research into women specific cancers. They strive to create clinical interventions and to extend disease knowledge so that fewer women receive a cancer diagnosis and treatment and quality of life are improved for those who do. In order to achieve this, the Department of Women's Cancer have developed an integrated research pathway including all women specific cancers for risk stratification, prevention, early detection and diagnosis, which incorporates clinical, epidemiological, genetic, epigenetic, proteomic, symptom and imaging data, and applies them to populations. http://www.instituteforwomenshealth.ucl.ac.uk/womens-cancer

About Elsevier Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make ground-breaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com

Media contact Nienke Swankhuisen
Elsevier
+31 204852445
n.swankhuisen@elsevier.com


ELSE PRESS RELEASES FROM THIS DATE:

New species of human relative discovered in S.A. cave

2015-09-10
The discovery of a new species of human relative was announced today, 10 September 2015, by the University of the Witwatersrand (Wits University), the National Geographic Society and the Department of Science and Technology (DST) and the National Research Foundation of South Africa (NRF). Besides shedding light on the origins and diversity of our genus, the new species, Homo naledi, appears to have intentionally deposited bodies of its dead in a remote cave chamber, a behaviour previously thought limited to humans. Consisting of more than 1 550 numbered fossil elements, ...

Drunk, distracted drivers are double dangers

2015-09-10
An accident waiting to happen: that's what an intoxicated driver is whose attention is further distracted by anything from a text message to dashboard controls. Such distractions are just too much to handle safely, even for people who drive while still within the legal alcohol limits, say Nicholas van Dyke and Mark Fillmore of the University of Kentucky in the US. Their study provides some of the first evidence on the degree to which distractions influence the ability of intoxicated drivers to safely control their vehicles. The findings are published in Springer's journal ...

New species emerges from the dark zone

2015-09-10
James Cook University scientists have played a role in a discovery that may alter the known history of humankind. JCU's Professor Paul Dirks and Dr Eric Roberts were part of a team that explored the Rising Star Cave system in South Africa. A chamber deep in the caves was found to contain multiple specimens of what is being called Homo naledi - an extinct, previously unknown species related to modern homosapiens. Testing at JCU and the University of Johannesburg shows sediments in the chamber did not come from external sources, ruling out the possibility of flash ...

Clearing a path for cancer research

2015-09-10
Researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry (MS) experiments. The study is published in Nature Communications. Understanding the biological signaling pathways that regulate metabolism and gene expression is challenging, because so many things are happening at once. But this understanding is crucial for knowing how a drug will affect healthy and cancer cells. Protein kinases play a pivotal role in these pathways by turning ...

Modeling the helicase to understand hepatitis C

Modeling the helicase to understand hepatitis C
2015-09-10
NS3 is an enzyme specific to the hepatitis C virus. If developed, a drug capable of recognizing and selectively attacking it could fight the disease without side effects for the body. However, to be able to develop one we need to know more about the behavior of this important protein in the virus replication process. Some SISSA scientists have provided a detailed and comprehensive view of the behavior of NS3. The study has been published in the journal Nucleic Acids Research. According to the WHO, a good 140 million people are affected by hepatitis C (3/4 million new cases ...

NYU researchers observe upward trend in hepatitis C infection rates among HIV+ MSM

2015-09-10
While sexual contact is not the most efficient means of hepatitis C (HCV) transmission, there have been several reports of outbreaks of sexually transmitted HCV in HIV-positive men who have sex with men (MSM). HCV infections are more likely to become persistent and to lead to progressive liver disease in people who are HIV-infected, even if they are receiving HIV treatment. Factors underlying these infections in HIV-positive MSM are only partially understood. Researchers at NYU's Center for Drug Use and HIV Research (CDUHR) at the College of Nursing (NYUCN) have conducted ...

Ultrafast uncoupled magnetism in atoms

2015-09-10
Future computers will require a magnetic material which can be manipulated ultra-rapidly by breaking the strong magnetic coupling. A study has been published in Nature Communications today in which Swedish and German scientists demonstrate that even the strongest magnetic coupling may be broken within picoseconds (10-12 s). This will open up an exciting new area of research. The element gadolinium is named after the Uppsala chemist Johan Gadolin who discovered the first rare-earth metal yttrium in the late 1700s. Gadolinium is in the same class of elements and it has ...

Genetic mutants alter entire biological communities

Genetic mutants alter entire biological communities
2015-09-10
Dublin, Thursday September 10th, 2015 - Scientists from Trinity College Dublin have discovered that one gene mutation in a single species can trigger dramatic changes in whole biological communities; changes can be as great as those caused by the extinction of a top predator. By using bacteria to replicate ecological systems in the lab, they found that mutations of a single gene that alter how one bacterial species interacts with others had huge structural impacts across their multi-species microbial communities. These 'social mutants' varied in their ability to produce ...

Understanding of complex networks could help unify gravity and quantum mechanics

Understanding of complex networks could help unify gravity and quantum mechanics
2015-09-10
Mathematicians investigating one of science's great questions -- how to unite the physics of the very big with that of the very small -- have discovered that when the understanding of complex networks such as the brain or the Internet is applied to geometry the results match up with quantum behavior. The findings, published today (Thursday) in Scientific Reports, by researchers from Queen Mary University of London and Karlsruhe Institute of Technology, could explain one of the great problems in modern physics. Currently ideas of gravity, developed by Einstein and Newton, ...

Oxygen is not definitive evidence of life on habitable extrasolar planets

Oxygen is not definitive evidence of life on habitable extrasolar planets
2015-09-10
This news release is available in Japanese. The Earth's atmosphere contains oxygen because plants continuously produce it through photosynthesis. This abundant supply of oxygen allows life forms like animals to flourish. Therefore, oxygen had been thought to be an essential biomarker for life on extrasolar planets. But now, a research assistant professor Norio Narita of the Astrobiology Center of National Institutes of Natural Sciences (NINS), which was founded in April 2015, and an associate professor Shigeyuki Masaoka, of the Institute of Molecular Science of NINS, ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Cancer preventative surgery could become a thing of the past, new research suggests
Two studies open the door to a new approach to breast and ovarian cancer prevention
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.